Utility of Hydroxypropylmethylcellulose Acetate Succinate (HPMCAS) for Initiation and Maintenance of Drug Supersaturation in the GI Milieu

PurposeTo identify materials and processes which effect supersaturation of the GI milieu for low solubility drugs in order to increase oral bioavailability.MethodsA variety of small and polymeric molecules were screened for their ability to inhibit drug precipitation in supersaturated solutions. The best polymeric materials were utilized to create spray-dried dispersions (SDDs) of drug and polymer, and these were tested for drug form and homogeneity. Dispersions were tested in vitro for their ability to achieve and maintain drug supersaturation, for a variety of drug structures.ResultsOf the 41 materials tested, HPMCAS was the most effective at maintaining drug supersaturation. Drug/HPMCAS SDDs were consistently more effective at achieving and maintaining drug supersaturation in vitro than were SDDs prepared with other polymers. Drug/HPMCAS SDDs were effective in vitro for eight low solubility drugs of widely varying structure. Drug/HPMCAS SDDs were more effective at achieving and maintaining supersaturation than were rotoevaporated Drug/HPMCAS dispersions or physical mixtures of Drug and HPMCAS. The degree of achievable drug supersaturation increased with increasing polymer content in the SDD. The drug in Drug /HPMCAS SDDs was amorphous, and the dispersions were demonstrated to have a single glass transition and were thus homogeneous.ConclusionHPMCAS has been identified as a uniquely effective polymer for use in SDDs of low solubility drugs, with broad applicability across a variety of drug structures and properties.

[1]  S. Riegelman,et al.  Oral absorption of griseofulvin in dogs: increased absorption via solid dispersion in polyethylene glycol 6000. , 1970, Journal of pharmaceutical sciences.

[2]  Christos Reppas,et al.  Biorelevant Dissolution Testing to Predict the Plasma Profile of Lipophilic Drugs After Oral Administration , 2001, Pharmaceutical Research.

[3]  S. Riegelman,et al.  Pharmaceutical applications of solid dispersion systems. , 1971, Journal of pharmaceutical sciences.

[4]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[5]  A. Serajuddin,et al.  Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. , 1999, Journal of pharmaceutical sciences.

[6]  James S. Taylor,et al.  Ideal Copolymers and the Second-Order Transitions of Synthetic Rubbers. I. Noncrystalline Copolymers , 1953 .

[7]  J. Sjövall Bile acids in man under normal and pathological conditions bile acids and steroids 73 , 1960 .

[8]  T. R. Bates,et al.  Some physical factors affecting the enhanced blepharoptotic activity of orally administered reserpine-cholanic acid coprecipitates. , 1969, Journal of pharmaceutical sciences.

[9]  C. Pouton,et al.  Enhancing intestinal drug solubilisation using lipid-based delivery systems. , 2008, Advanced drug delivery reviews.

[10]  W. Curatolo,et al.  Physical chemical properties of oral drug candidates in the discovery and exploratory development settings , 1998 .

[11]  S. Benita,et al.  Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. , 2004, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[12]  J Dressman,et al.  Improving drug solubility for oral delivery using solid dispersions. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[13]  Colin W Pouton,et al.  Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[14]  D. Horn,et al.  Chromatographic study of interactions between polyvinylpyrrolidone and drugs. , 1982, Journal of pharmaceutical sciences.

[15]  T. Higuchi,et al.  Study of possible complex formation between macromolecules and certain pharmaceuticals. I. Polyvinylpyrrolidone with sulfathiazole, procaine hydrochloride, sodium salicylate, benzyl penicillin, chloramphenicol, mandelic acid, caffeine, theophylline, and cortisone. , 1954, Journal of the American Pharmaceutical Association. American Pharmaceutical Association.

[16]  M Gibaldi,et al.  Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures. I. Theoretical considerations and discussion of the literature. , 1966, Journal of pharmaceutical sciences.

[17]  K. Johnson An Update. , 1984, Journal of food protection.

[18]  O. Hernell,et al.  Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human beings. , 1990, Biochemistry.

[19]  Joseph L. Kanig,et al.  Increasing Dissolution Rates and Gastrointestinal Absorption of Drugs via solid Solutions and Eutectic mixtures II: Experimental Evaluation of a Eutectic Mixture: Urea-acetaminophen System , 1966 .

[20]  S. Riegelman,et al.  Preparation and dissolution characteristics of several fast-release solid dispersions of griseofulvin. , 1969, Journal of pharmaceutical sciences.

[21]  D. T. Friesen,et al.  Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: an overview. , 2008, Molecular pharmaceutics.

[22]  Keiji Sekiguchi,et al.  Studies on Absorption of Eutectic Mixture. I. A Comparison of the Behavior of Eutectic Mixture of Sulfathiazole and that of Ordinary Sulfathiazole in Man. , 1961 .

[23]  T. Northfield,et al.  Postprandial concentrations of free and conjugated bile acids down the length of the normal human small intestine , 1973, Gut.

[24]  James S. Taylor,et al.  Ideal copolymers and the second‐order transitions of synthetic rubbers. i. non‐crystalline copolymers , 2007 .

[25]  T. R. Bates,et al.  In vitro dissolution and in vivo absorption of nitrofurantoin from deoxycholic acid coprecipitates. , 1973, Journal of pharmaceutical sciences.

[26]  Kevin C. Johnson,et al.  Guidance in the Setting of Drug Particle Size Specifications to Minimize Variability in Absorption , 1996, Pharmaceutical Research.

[27]  Christopher J H Porter,et al.  Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. , 2008, Advanced drug delivery reviews.

[28]  W I Higuchi,et al.  Dissolution rates of high energy sulfathiazole--povidone coprecipitates II: characterization of form of drug controlling its dissolution rate via solubility studies. , 1976, Journal of pharmaceutical sciences.

[29]  J. Dressman,et al.  Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. , 1997, Advanced drug delivery reviews.

[30]  Panos Macheras,et al.  A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system. , 2006, International journal of pharmaceutics.

[31]  D. Small,et al.  The physicochemical basis of cholesterol gallstone formation in man. , 1968, The Journal of clinical investigation.

[32]  J. Dressman,et al.  Dissolution Media Simulating Conditions in the Proximal Human Gastrointestinal Tract: An Update , 2008, Pharmaceutical Research.

[33]  P. Mahadevan,et al.  An overview , 2007, Journal of Biosciences.

[34]  D. Small,et al.  Lipid digestion and absorption. , 1983, Annual review of physiology.